Nomura Asset Management CO LTD Biotechnology

Nomura Asset Management CO LTD

$32.3 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
REGN Regeneron Pharmaceuticals, Inc.	$72.2B	$65.9 Million 0.2% of portfolio	92,514	Q4 2024 Added 7.57%
VRTX Vertex Pharmaceuticals Inc	$118B	$60.3 Million 0.19% of portfolio	149,799	Q4 2024 Reduced 3.29%
BMRN Biomarin Pharmaceutical Inc	$12.1B	$27.1 Million 0.08% of portfolio	412,299	Q4 2024 Reduced 15.1%
ALNY Alnylam Pharmaceuticals, Inc.	$31.6B	$19.5 Million 0.06% of portfolio	82,785	Q4 2024 Reduced 3.11%
UTHR United Therapeutics Corp	$16.9B	$8.69 Million 0.03% of portfolio	24,621	Q4 2024 Reduced 3.96%
INCY Incyte Corp	$15.7B	$4.43 Million 0.01% of portfolio	64,127	Q4 2024 Reduced 16.67%
MRNA Moderna, Inc.	$12.9B	$4.17 Million 0.01% of portfolio	100,180	Q4 2024 Reduced 12.38%
NVO Novo Nordisk A S	$176B	$3.77 Million 0.01% of portfolio	43,776	Q4 2024 Added 113.15%
TECH Bio Techne Corp	$2.59B	$3.32 Million 0.01% of portfolio	46,151	Q4 2024 Added 1.32%
ARGX Argenx Se	$35.4B	$2.86 Million 0.01% of portfolio	4,653	Q4 2024 Reduced 32.63%
ASND Ascendis Pharma A/S	$8.04B	$2.82 Million 0.01% of portfolio	20,506	Q4 2024 Added 13.92%
RPRX Royalty Pharma PLC	$14.1B	$2.59 Million 0.01% of portfolio	101,642	Q1 2023 Added 7.52%
ARVN Arvinas, Inc.	$974M	$1.74 Million 0.01% of portfolio	90,870	Q1 2023 New
BPMC Blueprint Medicines Corp	$5.61B	$1.54 Million 0.0% of portfolio	17,713	Q4 2024 Reduced 21.47%
VKTX Viking Therapeutics, Inc.	$2.26B	$867,000 0.0% of portfolio	21,551	Q4 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.9B	$380,000 0.0% of portfolio	56,310	Q1 2022 Sold Out
LEGN Legend Biotech Corp	$6.1B	$240,000 0.0% of portfolio	7,400	Q1 2023 Added 26.67%
JAZZ Jazz Pharmaceuticals PLC	$8.4B	$71,000 0.0% of portfolio	583	Q3 2022 Added 0.04%
EXEL Exelixis, Inc.	$11.3B	$50,000 0.0% of portfolio	1,520	Q1 2022 Reduced 44.74%
ETNB 89bio, Inc.	$511M	$0 0.0% of portfolio	0	Q4 2024 New
ADMA Adma Biologics, Inc.	$3.16B	$0 0.0% of portfolio	0	Q4 2024 New
APLS Apellis Pharmaceuticals, Inc.	$3.01B	$0 0.0% of portfolio	0	Q4 2024 New
ACLX Arcellx, Inc.	$2.79B	$0 0.0% of portfolio	0	Q4 2024 New
RNA Avidity Biosciences, Inc.	$1.68B	$0 0.0% of portfolio	0	Q4 2024 New
BNTX Bio N Tech Se	$29.1B	$0 0.0% of portfolio	0	Q4 2024 New
BBIO Bridge Bio Pharma, Inc.	$5.17B	$0 0.0% of portfolio	0	Q4 2024 New
CLDX Celldex Therapeutics, Inc.	$1.06B	$0 0.0% of portfolio	0	Q4 2024 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.89B	$0 0.0% of portfolio	0	Q4 2024 New
CYTK Cytokinetics Inc	$4.35B	$0 0.0% of portfolio	0	Q4 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$901M	$0 0.0% of portfolio	0	Q4 2024 New
DNLI Denali Therapeutics Inc.	$2.87B	$0 0.0% of portfolio	0	Q4 2024 Sold Out
EWTX Edgewise Therapeutics, Inc.	$1.64B	$0 0.0% of portfolio	0	Q4 2024 New
GMAB Genmab A/S	$14B	$0 0.0% of portfolio	0	Q4 2024 New
IDYA Ideaya Biosciences, Inc.	$998M	$0 0.0% of portfolio	0	Q4 2024 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	0	Q4 2024 New
INSM Insmed Inc	$10.7B	$0 0.0% of portfolio	0	Q4 2024 New
NTLA Intellia Therapeutics, Inc.	$813M	$0 0.0% of portfolio	0	Q4 2024 New
IOVA Iovance Biotherapeutics, Inc.	$879M	$0 0.0% of portfolio	0	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.55B	$0 0.0% of portfolio	0	Q4 2024 New
KRYS Krystal Biotech, Inc.	$3.93B	$0 0.0% of portfolio	0	Q4 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.77B	$0 0.0% of portfolio	0	Q4 2024 New
MRUS Merus N.V.	$1.84B	$0 0.0% of portfolio	0	Q4 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.84B	$0 0.0% of portfolio	0	Q4 2024 New
MLTX Moon Lake Immunotherapeutics	$1.61B	$0 0.0% of portfolio	0	Q4 2024 New
NRIX Nurix Therapeutics, Inc.	$828M	$0 0.0% of portfolio	0	Q4 2024 New
NUVL Nuvalent, Inc.	$3.35B	$0 0.0% of portfolio	0	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$195M	$0 0.0% of portfolio	0	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$160M	$0 0.0% of portfolio	0	Q4 2024 New
PTGX Protagonist Therapeutics, Inc	$1.9B	$0 0.0% of portfolio	0	Q4 2024 New
PTCT Ptc Therapeutics, Inc.	$3.71B	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.